266 related articles for article (PubMed ID: 34051804)
1. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
Havla J; Pakeerathan T; Schwake C; Bennett JL; Kleiter I; Felipe-Rucián A; Joachim SC; Lotz-Havla AS; Kümpfel T; Krumbholz M; Wendel EM; Reindl M; Thiels C; Lücke T; Hellwig K; Gold R; Rostasy K; Ayzenberg I
J Neuroinflammation; 2021 May; 18(1):121. PubMed ID: 34051804
[TBL] [Abstract][Full Text] [Related]
2. Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode.
Pakeerathan T; Havla J; Schwake C; Salmen A; Bigi S; Abegg M; Brügger D; Ferrazzini T; Runge AK; Breu M; Kornek B; Bsteh G; Felipe-Rucián A; Ringelstein M; Aktas O; Karenfort M; Wendel E; Kleiter I; Hellwig K; Kümpfel T; Thiels C; Lücke T; Gold R; Rostasy K; Ayzenberg I
J Neurol; 2022 Dec; 269(12):6366-6376. PubMed ID: 35869995
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Retinal Changes in MOGAD.
Oertel FC; Sotirchos ES; Zimmermann HG; Motamedi S; Specovius S; Asseyer ES; Chien C; Cook L; Vasileiou E; Filippatou A; Calabresi PA; Saidha S; Pandit L; D'Cunha A; Outteryck O; Zéphir H; Pittock S; Flanagan EP; Bhatti MT; Rommer PS; Bsteh G; Zrzavy T; Kuempfel T; Aktas O; Ringelstein M; Albrecht P; Ayzenberg I; Pakeerathan T; Knier B; Aly L; Asgari N; Soelberg K; Marignier R; Tilikete CF; Cobo Calvo A; Villoslada P; Sanchez-Dalmau B; Martinez-Lapiscina EH; Llufriu S; Green AJ; Yeaman MR; Smith TJ; Brandt AU; Chen J; Paul F; Havla J;
Ann Neurol; 2022 Sep; 92(3):476-485. PubMed ID: 35703428
[TBL] [Abstract][Full Text] [Related]
4. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
Pache F; Zimmermann H; Mikolajczak J; Schumacher S; Lacheta A; Oertel FC; Bellmann-Strobl J; Jarius S; Wildemann B; Reindl M; Waldman A; Soelberg K; Asgari N; Ringelstein M; Aktas O; Gross N; Buttmann M; Ach T; Ruprecht K; Paul F; Brandt AU;
J Neuroinflammation; 2016 Nov; 13(1):282. PubMed ID: 27802824
[TBL] [Abstract][Full Text] [Related]
5. Early retinal atrophy predicts long-term visual impairment after acute optic neuritis.
Sanchez-Dalmau B; Martinez-Lapiscina EH; Torres-Torres R; Ortiz-Perez S; Zubizarreta I; Pulido-Valdeolivas IV; Alba-Arbalat S; Guerrero-Zamora A; Calbet D; Villoslada P
Mult Scler; 2018 Aug; 24(9):1196-1204. PubMed ID: 28669275
[TBL] [Abstract][Full Text] [Related]
6. Myelin Oligodendrocyte Glycoprotein Antibody Disease Optic Neuritis: A Structure-Function Paradox?
Ross R; Kenney R; Balcer LJ; Galetta SL; Krupp L; O'Neill KA; Grossman SN
J Neuroophthalmol; 2024 Jun; 44(2):172-177. PubMed ID: 38526582
[TBL] [Abstract][Full Text] [Related]
7. Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Bollo L; Arrambide G; Cobo-Calvo A; Alvarez JV; Alberich M; Cabello S; Castilló J; Galan I; Midaglia LS; Acevedo BR; Zabalza A; Pappolla A; Mongay Ochoa N; Tintore M; Rio J; Comabella M; Tur C; Auger C; Sastre-Garriga J; Rovira A; Montalban X; Pareto D; Vidal-Jordana A
Neurology; 2024 Apr; 102(7):e209156. PubMed ID: 38447105
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study.
Oertel FC; Outteryck O; Knier B; Zimmermann H; Borisow N; Bellmann-Strobl J; Blaschek A; Jarius S; Reindl M; Ruprecht K; Meinl E; Hohlfeld R; Paul F; Brandt AU; Kümpfel T; Havla J
J Neuroinflammation; 2019 Jul; 16(1):154. PubMed ID: 31345223
[TBL] [Abstract][Full Text] [Related]
9. Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Gericke FC; Hanson JVM; Hackenberg A; Gerth-Kahlert C
Eur J Paediatr Neurol; 2024 Jan; 48():113-120. PubMed ID: 38217965
[TBL] [Abstract][Full Text] [Related]
10. Bilateral retinal pathology following a first-ever clinical episode of autoimmune optic neuritis.
Wicki CA; Manogaran P; Simic T; Hanson JVM; Schippling S
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31969471
[TBL] [Abstract][Full Text] [Related]
11. Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis.
Balk LJ; Coric D; Nij Bijvank JA; Killestein J; Uitdehaag BM; Petzold A
Mult Scler; 2018 May; 24(6):767-776. PubMed ID: 28511578
[TBL] [Abstract][Full Text] [Related]
12. OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.
Chen JJ; Sotirchos ES; Henderson AD; Vasileiou ES; Flanagan EP; Bhatti MT; Jamali S; Eggenberger ER; Dinome M; Frohman LP; Arnold AC; Bonelli L; Seleme N; Mejia-Vergara AJ; Moss HE; Padungkiatsagul T; Stiebel-Kalish H; Lotan I; Hellmann MA; Hodge D; Oertel FC; Paul F; Saidha S; Calabresi PA; Pittock SJ
Mult Scler Relat Disord; 2022 Feb; 58():103525. PubMed ID: 35038647
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis].
Song HL; Wei SH
Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):174-179. PubMed ID: 30841683
[No Abstract] [Full Text] [Related]
14. Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
Esen E; Sizmaz S; Balal M; Yar K; Demirkiran M; Unal I; Demircan N
Curr Eye Res; 2016 Oct; 41(10):1353-1358. PubMed ID: 26882356
[TBL] [Abstract][Full Text] [Related]
15. Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders.
Gigengack NK; Oertel FC; Motamedi S; Bereuter C; Duchow A; Rust R; Bellmann-Strobl J; Ruprecht K; Schmitz-Hübsch T; Paul F; Brandt AU; Zimmermann HG
Sci Rep; 2022 Oct; 12(1):17545. PubMed ID: 36266394
[TBL] [Abstract][Full Text] [Related]
16. Change in visual acuity and retinal structures following Repository Corticotropin Injection (RCI) therapy in patients with acute demyelinating optic neuritis: Improvement in low contrast visual acuity in both affected and contralateral eyes in a single-armed open-label study.
Scannell Bryan M; Sergott RC
J Neurol Sci; 2019 Dec; 407():116505. PubMed ID: 31706456
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.
Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802
[TBL] [Abstract][Full Text] [Related]
18. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients.
Narayan RN; McCreary M; Conger D; Wang C; Greenberg BM
Mult Scler Relat Disord; 2019 Feb; 28():86-90. PubMed ID: 30576847
[TBL] [Abstract][Full Text] [Related]
19. Subclinical optic neuritis in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease.
Nguyen L; Wang CX; Conger DL; Sguigna PV; Singh S; Greenberg BM
Mult Scler Relat Disord; 2023 Aug; 76():104802. PubMed ID: 37329787
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study.
Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G
Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
